Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Oral Oncol. 2016 Sep 6;61:89–97. doi: 10.1016/j.oraloncology.2016.08.017

Table 2.

Statistical Correlation of Clinical Variables to Histologic Subtypes in HNRMS

Clinical variables Histologic subtype
P value (Fisher's exact)*
ARMS (n = 33) ERMS (n = 53) SRMS-ScRMS (n = 13)
Gender 0.541
Male 19 58% 25 47% 8 61%
Female 14 42% 28 53% 5 39%

Age (years) Mean 23 8.7 29 <0.001 (ANOVA)
Median 23 6 28 <0.001 Kruskal-Wallis
Max. 57 38 72
Min. 0.08 0.3 0.7

Age group <0.001
Adult 22 67% 7 13% 8 61%
Pediatric 11 33% 46 87% 5 39%

Tumor site <0.001
PM 28 85% 33 62% 3 23%
S 4 12% 11 21% 10 77%
O 1 3% 9 17% 0 0%

Tumor size Mean 4 4 5 0.344 (ANOVA)
Median 4 4 5 0.517 Kruskal-Wallis
Max. 9 12 10
Min. 1 1.3 0.8

Regional lymph node <0.001
Positive 24 72% 14 27% 2 17%
Negative 9 28% 38 73% 10 83%

Initial metastasis 0.078
Positive 10 30% 6 11% 3 23%
Negative 23 70% 47 89% 10 77%

Stage 0.001
1 4 12% 16 30% 9 69%
2 2 6% 8 15% 0 0%
3 17 52% 23 44% 1 8%
4 10 30% 6 11% 3 23%

Recurrence 0.001
LR 6 18% 3 6% 2 18%
DR, (LR & DR) 8 24% 1 2% 2 18%
NR 19 58% 49 92% 7 64%

Vital status 0.05
Alive 20 61% 43 81% 6 54%
Deceased 13 39% 10 19% 5 46%

Follow-up duration (months) Mean 63 106 35 <0.001 (ANOVA)
Median 32 104 29 <0.001 Kruskal-Wallis
Max. 232 232 94
Min. 4 7 4

PM – Parameningeal, S – Non parameningeal non orbital, O – Orbital, LR – Local recurrence, DR – Distant recurrence, NR – No recurrence

*

P values calculated with Fisher's exact if not otherwise specified